O. Y. Voskoboynik, “Synthesis, anticancer and FGFR1 inhibitory activity of isoindolo[2,1-a][1,2,4]triazino[2,3-c]quinazoline derivatives”, MCCh, no. 1, pp. 5–18, Apr. 2016.